X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13412) 13412
Newsletter (121) 121
Book Chapter (30) 30
Newspaper Article (26) 26
Magazine Article (19) 19
Dissertation (9) 9
Publication (3) 3
Book / eBook (2) 2
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10585) 10585
tacrolimus (6858) 6858
tacrolimus - therapeutic use (6758) 6758
immunosuppressive agents - therapeutic use (6736) 6736
male (6637) 6637
female (6144) 6144
transplantation (5950) 5950
adult (4691) 4691
middle aged (4333) 4333
surgery (4221) 4221
immunology (3416) 3416
cyclosporine (2460) 2460
treatment outcome (2380) 2380
animals (2362) 2362
cyclosporine - therapeutic use (2206) 2206
tacrolimus - administration & dosage (2001) 2001
immunosuppressive agents - adverse effects (1974) 1974
kidney transplantation (1884) 1884
immunosuppression (1844) 1844
aged (1821) 1821
immunosuppressive agents - administration & dosage (1763) 1763
tacrolimus - adverse effects (1762) 1762
adolescent (1755) 1755
drug therapy, combination (1688) 1688
graft rejection - prevention & control (1686) 1686
pharmacology & pharmacy (1645) 1645
retrospective studies (1614) 1614
child (1600) 1600
time factors (1470) 1470
recipients (1434) 1434
calcineurin inhibitors (1361) 1361
follow-up studies (1342) 1342
mycophenolic acid - analogs & derivatives (1331) 1331
mycophenolic acid - therapeutic use (1283) 1283
fk506 (1281) 1281
kidneys (1264) 1264
kidney transplantation - immunology (1255) 1255
dermatology (1243) 1243
liver transplantation (1127) 1127
rats (1051) 1051
risk factors (1034) 1034
analysis (1015) 1015
therapy (1013) 1013
immunosuppressive agents - pharmacokinetics (1009) 1009
tacrolimus - pharmacology (970) 970
immunosuppressive agents (956) 956
pharmacokinetics (954) 954
liver (943) 943
graft survival (933) 933
child, preschool (924) 924
tacrolimus - pharmacokinetics (911) 911
mycophenolate-mofetil (895) 895
young adult (882) 882
immunotherapy (867) 867
health aspects (859) 859
rejection (832) 832
cyclosporine-a (823) 823
prospective studies (801) 801
fk-506 (800) 800
liver transplantation - immunology (794) 794
immunosuppressive agents - pharmacology (792) 792
tacrolimus - blood (765) 765
children (759) 759
organ transplant recipients (756) 756
pediatrics (754) 754
transplants & implants (754) 754
sirolimus (722) 722
transplantation, homologous (721) 721
renal-transplantation (718) 718
dose-response relationship, drug (711) 711
graft rejection (708) 708
efficacy (706) 706
immunosuppressive agents - blood (679) 679
cyclosporine - adverse effects (678) 678
mycophenolate mofetil (667) 667
kidney-transplantation (664) 664
sirolimus - therapeutic use (653) 653
graft rejection - drug therapy (652) 652
corticosteroids (641) 641
kidney transplantation - adverse effects (640) 640
urology & nephrology (634) 634
graft rejection - immunology (632) 632
gastroenterology & hepatology (622) 622
care and treatment (611) 611
mice (610) 610
graft survival - drug effects (608) 608
administration, topical (605) 605
medicine & public health (605) 605
infant (596) 596
research (592) 592
biopsy (580) 580
tacrolimus - analogs & derivatives (566) 566
drug therapy (563) 563
antibodies, monoclonal - therapeutic use (556) 556
immunosuppression - methods (548) 548
adrenal cortex hormones - therapeutic use (541) 541
disease (527) 527
graft rejection - epidemiology (522) 522
dermatitis, atopic - drug therapy (519) 519
safety (519) 519
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13317) 13317
Japanese (115) 115
Spanish (89) 89
French (86) 86
German (75) 75
Chinese (46) 46
Portuguese (25) 25
Polish (17) 17
Italian (11) 11
Korean (8) 8
Dutch (5) 5
Finnish (5) 5
Norwegian (5) 5
Czech (3) 3
Hungarian (3) 3
Russian (3) 3
Turkish (3) 3
Danish (2) 2
Hebrew (2) 2
Icelandic (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2005, Volume 6, Issue 2, 11
.... Since there are almost no randomized, controlled, double-blind studies comparing the use of various therapeutic agents in this condition, treatment decisions still rely heavily on individual clinicians experience... 
Methotrexate, therapeutic use | Mitomycin, therapeutic use | Tetracyclines, therapeutic use | Sulfasalazine, therapeutic use | Tacrolimus, therapeutic use | Nicotinamide, therapeutic use | Cyclophosphamide, therapeutic use | Mycophenolate mofetil, therapeutic use | Pemphigoid, treatment | Calcineurin inhibitors, therapeutic use | Azathioprine, therapeutic use | Leflunomide, therapeutic use | Immunoglobulins, therapeutic use | Interferon alpha 2b, therapeutic use | Corticosteroids, therapeutic use | Sulfapyridine, therapeutic use | Sulfamethoxypyridazine, therapeutic use | Thalidomide, therapeutic use | Ciclosporin, therapeutic use | Prednisone, therapeutic use | Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | PLASMA-EXCHANGE | IMMUNOSUPPRESSIVE THERAPY | TOPICAL CYCLOSPORINE | MITOMYCIN-C | PASSIVE TRANSFER | INTRAVENOUS IMMUNOGLOBULIN THERAPY | SYSTEMIC CHEMOTHERAPY | THALIDOMIDE THERAPY | NECROSIS-FACTOR-ALPHA | MYCOPHENOLATE-MOFETIL | DERMATOLOGY | Calcineurin Inhibitors | Pemphigoid, Benign Mucous Membrane - therapy | Antibiotics, Antineoplastic - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Mitomycin - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Administration, Topical | Tetracyclines - therapeutic use | Plasmapheresis
Book Review
Seminars in nephrology, ISSN 0270-9295, 2015, Volume 35, Issue 5, pp. 509 - 520
Journal Article
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 2004, Volume 5, Issue 6, pp. 417 - 422
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Highlights • Role of immune checkpoint inhibition in the management of key malignancies. • Description of rates of immune-related adverse events and timing of... 
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | OPEN-LABEL | SINGLE-ARM | ANTI-CTLA-4 ANTIBODY | METASTATIC MELANOMA | ONCOLOGY | ADVANCED MELANOMA | LONG-TERM SAFETY | MALIGNANT MESOTHELIOMA | ENTERIC NEUROPATHY | ADVERSE EVENTS | IPILIMUMAB RETREATMENT | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10063, pp. 3006 - 3016
Journal Article
The Medical clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 497 - 523
Therapy for autoimmune demyelinating disorders has evolved rapidly over the past 10 years to include traditional immunosuppressants as well as novel... 
Autoimmune encephalopathy | Intravenous immunoglobulin | Multiple sclerosis | Neuromyelitis optica | Myasthenia gravis | Paraneoplastic neurologic disorders | PARANEOPLASTIC CEREBELLAR DEGENERATION | INCLUSION-BODY MYOSITIS | STIFF PERSON SYNDROME | PROGRESSIVE MULTIPLE-SCLEROSIS | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | NEUROMYELITIS-OPTICA | DOUBLE-BLIND | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | PLACEBO-CONTROLLED TRIAL | MYASTHENIA-GRAVIS | Azathioprine - therapeutic use | Natalizumab | Humans | Immunosuppressive Agents - therapeutic use | Glatiramer Acetate | Plasma Exchange | Adrenal Cortex Hormones - therapeutic use | Cyclophosphamide - therapeutic use | Interferon-beta - therapeutic use | Propylene Glycols - therapeutic use | Adjuvants, Immunologic - therapeutic use | Mitoxantrone - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Fingolimod Hydrochloride | Rituximab | Nervous System Diseases - therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Sphingosine - analogs & derivatives | Interferon beta-1b | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Interferon beta-1a | Sphingosine - therapeutic use | Nervous System Diseases - immunology | Peptides - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use
Journal Article
Cochrane database of systematic reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, p. CD003594
Journal Article